Veterinary Medicines

CLOTEAN – inj. ad us. vet.

Authorised
  • Clostridium tetani, antitoxin
Download as PDF

Product identification

Medicine name:
CLOTEAN – inj. ad us. vet.
Active substance:
  • Clostridium tetani, antitoxin
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Dog
  • Cat
Route of administration:
  • Subcutaneous use
  • Intramuscular and intravenous use

Product details

Active substance and strength:
  • Clostridium tetani, antitoxin
    300.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Horse
    • Cattle
    • Sheep
    • Goat
    • Pig
    • Dog
    • Cat
  • Intramuscular and intravenous use
    • Horse
    • Cattle
    • Sheep
    • Goat
    • Pig
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AM01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-1459
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/05/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."